New Leaf’s investment strategy... execute NLV-III’s targeted strategy
HOUSE_OVERSIGHT_024017.jpg
This document is page 6 of a confidential investment memorandum for New Leaf Ventures III (NLV-III). It outlines the fund's investment strategy, which focuses primarily on the Biopharmaceutical and Information Convergence sectors in the U.S., with a specific emphasis on targeted therapeutics and molecular mechanisms. The document highlights favorable market conditions and a cooperative regulatory environment with the FDA as key drivers for the fund's potential success.
Entities connected to both New Leaf and NLV-III
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein relationship